text: According to Addiction Center, in recent years, a new form of substance abuse is becoming increasingly common among stay-at-home moms and CEOs alike: microdosing LSD. Microdosing refers to taking a small fraction of what is considered a recreational dose of LSD or other hallucinogen (like psilocybin mushrooms, also known as magic mushrooms).
  Reportedly, microdosing certain psychedelic drugs can improve mood, induce physical and mental stimulation, and encourage creative thinking. Emerging studies support the notion that hallucinogenic drugs, taken in small doses or under the supervision and guidance of a medical professional, can be used to treat mental health issues such as depression, anxiety, and PTSD. However, taking consistent and frequent doses of any drug, especially one as potent as LSD, is by no means safe for all individuals and may put certain people at a high risk for developing addiction.
  Given many hallucinogens’ status as Schedule I drugs, it is difficult to conduct FDA-approved scientific studies. Moreover, most microdosing studies rely on reporting and statistics provided by self-proclaimed “microdosers” who would likely have a positive bias regarding the practice. Subsequently, legitimate claims made regarding mental health treatment with psychedelics remain rare.
  Get a Roundup of Psychedelic News Stories in Your Inbox.
  [contact-form-7 id="44" title="Newsletter Subscription Form"]
  By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
  Psychedelic Spotlight
  Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
  Company
  Home
  About
  Work With Us
  News
  Privacy Policy
  Terms and Conditions
  Resources
  Conferences
  Experts
  Glossary
  Therapy
  Subscribe
  Email(Required)
  Δ
  © 2021 Psychedelic Spotlight. All rights reserved. Owned and operated by Global Trac Solutions, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.
  Scroll to top
  Get a Roundup of Psychedelic News Stories in Your Inbox.
  Email(Required)
  Δ
  By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.